Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive. OGLEMILAST is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include oglemilastum and GRC 3886. Its PubChem CID is 11387409.
Oglemilast
| CAS No | 778576-62-8 |
|---|---|
| Molecular Formula | C20H13Cl2F2N3O5S |
| Molecular Weight | 516.3 g/mol |
| Synonyms | N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)-8-(methanesulfonamido)dibenzofuran-1-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive. OGLEMILAST is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.
The listed CAS number is 778576-62-8.
The listed molecular formula is C20H13Cl2F2N3O5S.
The listed molecular weight is 516.3 g/mol.
N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)-8-(methanesulfonamido)dibenzofuran-1-carboxamide.
The source lists oglemilastum and GRC 3886.